Cargando…
Short term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein E during initial BTK inhibitor therapy for CLL or lymphoplasmacytic lymphoma
Autores principales: | Zent, Clive S., Brady, Michael T., Delage, Carolyne, Strawderman, Myla, Laniewski, Nathan, Contant, Phuong N., Kanagaiah, Preshetha, Sangster, Mark Y., Barr, Paul M., Chu, Charles C., Topham, David J., Friedberg, Jonathan W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596619/ https://www.ncbi.nlm.nih.gov/pubmed/33128020 http://dx.doi.org/10.1038/s41375-020-01074-4 |
Ejemplares similares
-
S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit
por: Nguyen-Contant, Phuong, et al.
Publicado: (2020) -
BTK inhibitors impair humoral and cellular responses to recombinant zoster vaccine in CLL
por: Pleyer, Christopher, et al.
Publicado: (2022) -
Formation and Expansion of Memory B Cells against Coronavirus in Acutely Infected COVID-19 Individuals
por: Embong, A. Karim, et al.
Publicado: (2022) -
Squalene-Based Influenza Vaccine Adjuvants and Their Impact on the Hemagglutinin-Specific B Cell Response
por: Nguyen-Contant, Phuong, et al.
Publicado: (2021) -
Second Cancer Incidence in CLL Patients Receiving BTK Inhibitors
por: Bond, David A, et al.
Publicado: (2020)